October 31, 2012
Bayer HealthCare of Germany has announced positive results from CHEST-1, a multinational PIII clinical trial of the pulmonary hypertension treatment riociguat, which was conducted in 261 patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) or with persistent or recurrent pulmonary...read more